Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study

Table 2

Characteristics at baseline before PSM: Xiyanping combination versus cephalosporin.

Variable	Xiyanping combination		Cephalosporin		P
	N	%	N	%
Sample size	186	6.2%	2791	93.8%
Age (y), mean ± SD	57.10±19.52		64.56±16.10		<0.001
Gender
Male	95	51.1%	1405	50.3%	0.846
Female	91	48.9%	1386	49.7%	0.846
Marriage
Widowed	3	1.6%	70	2.5%	0.442
Married	147	79.0%	2444	87.8%	0.001
Single	35	18.8%	266	9.6%	<0.001
Divorced or others	1	0.5%	4	0.1%	0.204
Occupation
Peasants	42	25.8%	1491	56.7%	<0.001
Employment	71	43.6%	601	22.9%	<0.001
Unemployment	0	0.0%	15	0.6%	0.333
Retirement	7	4.3%	180	6.8%	0.206
Unknown	35	21.5%	233	8.9%	<0.001
Others	8	4.9%	108	4.1%	0.620
Comorbidities
Yes	8	4.3%	13	0.5%	<0.001
No	178	95.7%	2778	99.5%	<0.001
CRP difference	60.51±51.43		38.77±54.65		0.002
Neutrophil proportion difference	79.82±13.51		73.60±13.43		0.001
Neutrophil count difference	8.06±4.73		6.62±4.76		0.027
White blood cell count difference	9.80±4.92		8.99±11.46		0.258